IP Library Granted Patent US 9,187,342
Granted Patent B2
US 9,187,342 · App. 13/159,683 · Granted Nov 17, 2015

Method for removing drugs from waste water using neutralized bauxite residue

Inventors: Shannon L. Isovitsch Parks (Sarver, PA); David Iwig (Greensburg, PA); John R. Smith (Pittsburgh, PA); Jaw K. Fu (Murrysville, PA); Rajat Ghosh (Murrysville, PA)
Assignee: Alcoa Inc.
C02F1/281B01J20/0229B01J20/06B01J20/08B01J20/12B01J20/16B01J20/28004B01J20/28057B01J2220/42B01J2220/56C02F1/288C02F1/74C02F3/327C02F2101/103C02F2101/16C02F2101/20C02F2101/30C02F2101/305C02F2209/003C02F2209/06C02F2209/08C02F2209/10C02F2209/14C02F2209/18C02F2209/22C02F2209/40C02F2303/04
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,187,342
App. No.
13/159,683
Granted
Nov 17, 2015
Kind
B2
Abstract

The instant disclosure relates to methods, systems, and apparatus for polishing wastewater (i.e. non-potable water) using filtration media. More particularly, the instant disclosure relates to wastewater polishing using a bed of mixed metal oxides under certain operating conditions to remove a plurality of contaminants from a wastewater stream.

Claims (10)

1. A method comprising:

(a) dissolving at least 5 ppm oxygen into a wastewater stream, wherein the wastewater stream comprises a contaminant profile including at least one drug at an initial drug concentration, wherein said at least one drug is selected from the group consisting of gemfibrozil, hydrochlorothiazide, 2-hydroxy-ibuprofen, ibuprofen, naproxen, triclocarban, triclosan, acetaminophen, azithromycin, caffeine, ciprofloxacin, clarithromycin, cloxacillin, diphenhydramine, diltiazem, erythromycin-H 2 O, fluoxetine, miconazole, norfloxacin, ofloxacin, penicillin V, sulfadiazine, sulfamethoxazole, thiabendazole, trimethoprim, 1,7-dimethlxanthine, cholesterol, and combinations thereof;

(b) flowing the wastewater stream having at least about 5 ppm oxygen dissolved therein into a particulate bed comprising neutralized bauxite residue particles, the bauxite residue particles having an average particle size of less than about 2 inches;

(d) removing at least some of said at least one drug from the wastewater stream to produce a cleaned water stream, wherein the cleaned water stream comprises a final drug concentration less than the initial drug concentration.

2. The method of claim 1 , wherein the removing step comprises removing at least about 40% of said at least one drug from the initial contaminant concentration.

3. The method of claim 1 , further comprising maintaining the pH of the wastewater stream within the range of from about 3 to about 9.

4. The method of claim 1 , wherein the bed comprises a hydraulic loading rate of the wastewater stream onto the bed of not greater than about 0.5 gal/min/ft.

5. The system of claim 1 , wherein the bed comprises a hydraulic conductivity of the wastewater stream through the bed of not greater than about 0.19 cm/s.

6. The method of claim 1 , wherein the particulate bed of neutralized bauxite residue comprises a hydraulic residence time of the wastewater stream in the particulate bed of neutralized bauxite residue of not less than about 33 minutes.

7. The method of claim 1 , wherein the particulate bed of neutralized bauxite residue comprises a field capacity of at least about 50%.

Assignments (2)
CHANGE OF NAME Recorded Nov 11, 2016
From: ALCOA INC.
To: ARCONIC INC.
Reel/Frame 040599/0309 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 15, 2011
From: ISOVITSCH PARKS, SHANNON L.; IWIG, DAVID; SMITH, JOHN R.; GHOSH, RAJAT; FU, JAW K.
To: ALCOA INC.
Reel/Frame 026446/0028 →
Continuity (2)
Provisional Application 61354448 · Jun 14, 2010
Related Publication 20110303609A1 · Dec 15, 2011